Sucralfate dispersible tablets

Reproductive toxicity: When rats were given sucralfate at a dose of 38 times the human dose, their fertility was not significantly affected. When rats, mice and rabbits were given at a dose of 50 times the human dose, no teratogenic effects on animal fetuses were observed. Due to the lack of adequate and strictly controlled clinical research data on the use of this product in pregnant women, and the results of animal reproductive toxicity studies cannot fully represent the results of human trials, pregnant women can only take this product when it is really necessary. It is not clear whether sucralfate is secreted through breast milk. Since many drugs can be secreted through breast milk, lactating women should use this product with caution. Carcinogenicity: Rats and mice were orally given 1g/kg of sucralfate (12 times the human dose) for 24 consecutive months, and the results showed no carcinogenicity.

Molecular weight: C11H52Al16O75S8-16

This product is white tablets.

Used for chronic gastritis and to relieve stomach pain, heartburn and acid reflux caused by excessive gastric acid.

Place the tablet in a little warm water 1 hour before meals and before going to bed, shake well and drink. Adults take 2 tablets at a time, 3 to 4 times a day. The course of treatment is 4 to 6 weeks, or as directed by the doctor.

The most common adverse reaction is constipation. The less common or occasional adverse reactions include low back pain, diarrhea, nausea, dizziness, drowsiness, dry mouth, indigestion, fatigue, rash, itching, back pain and stomach cramps.

It is contraindicated for people with habitual constipation.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Use with caution in the first three months of pregnancy. Precautions for the elderly: Not yet clear.

1. This product should not be taken together with tetracyclines, cimetidine, phenytoin sodium, warfarin, various vitamins, fluoroquinolones, digoxin, etc., as it can reduce the absorption of these drugs. 2. When used with multienzyme tablets, the efficacy of both drugs is reduced. 3. If used with other drugs at the same time, drug interactions may occur. Please consult a physician or pharmacist for details.

Sealed, store in a dry place.

0.25g

24 months

Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.

• Founded in:

  1999-03-03

• Address:

  No. 2 Dashizhi Road, Nan'an Economic and Technological Development Zone, Chongqing

• Tax NO.:

  915001082031636780

• Registered Funds:

  110.6375 million yuan

• Website:

  Log in to view

• Email:

  Log in to view